학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 25건 | 목록 1~20
Academic Journal
Peters S; Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland. Electronic address: Solange.Peters@chuv.ch.; Oliner KS; AstraZeneca, Gaithersburg, USA.; L'Hernault A; AstraZeneca, Cambridge, UK.; Ratcliffe M; AstraZeneca, Cambridge, UK.; Madison H; AstraZeneca, Gaithersburg, USA.; Lai Z; AstraZeneca, Waltham, USA.; Stewart R; AstraZeneca, Cambridge, UK.; Mann H; AstraZeneca, Cambridge, UK.; Lowery C; AstraZeneca, Gaithersburg, USA.; Garon EB; David Geffen School of Medicine at UCLA, Los Angeles, USA.; Mok T; State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, China.; Johnson ML; Sarah Cannon Research Institute, SCRI Oncology Partners, Nashville, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Borghaei H; Hematology and Oncology Department, Fox Chase Cancer Center, Philadelphia, USA. Electronic address: Hossein.Borghaei@fccc.edu.; de Marinis F; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy.; Dumoulin D; Department of Pulmonary Medicine, Erasmus Medisch Centrum, Rotterdam, the Netherlands.; Reynolds C; Ocala Cancer Center, Florida Cancer Specialists and Research Institute - North Region (SCRI), Ocala, USA.; Theelen WSME; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Percent I; North Port Cancer Center, Florida Cancer Specialists and Research Institute - South Region (SCRI), Port Charlotte, USA.; Gutierrez Calderon V; Department of Medical Oncology, Hospital Regional Universitario de Málaga, Málaga, Spain.; Johnson ML; Department of Medical Oncology, Sarah Cannon Research Institute, Tennessee Oncology, Nashville, USA.; Madroszyk-Flandin A; Department of Medicine, Institut Paoli-Calmettes, Marseille, France.; Garon EB; Division of Hematology-Oncology, David Geffen School of Medicine, University of California, Los Angeles.; He K; Comprehensive Cancer Center, Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA.; Planchard D; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.; Reck M; Department of Thoracic Oncology, LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.; Popat S; Lung Unit, Department of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.; Herbst RS; Section of Medical Oncology, Yale University, New Haven.; Leal TA; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta.; Shazer RL; Department of Clinical Research and Development, Mirati Therapeutics, Inc., San Diego, USA.; Yan X; Department of Clinical Research and Development, Mirati Therapeutics, Inc., San Diego, USA.; Harrigan R; Department of Clinical Research and Development, Mirati Therapeutics, Inc., San Diego, USA.; Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Rodríguez-Abreu D; Medical Oncology, Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain. Electronic address: drodabr@gobiernodecanarias.org.; Powell SF; Oncology, Sanford Health, Sioux Falls, USA.; Hochmair MJ; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria.; Gadgeel S; Thoracic Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, USA.; Esteban E; Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain.; Felip E; Medical Oncology Department, Vall d'Hebron University, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Speranza G; Centre Integré de Cancérologie de la Montérégie, Hôpital Charles-Le Moyne, Greenfield Park, Canada.; De Angelis F; Centre Integré de Cancérologie de la Montérégie, Hôpital Charles-Le Moyne, Greenfield Park, Canada.; Dómine M; Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz, IIS-FJD, Madrid, Spain.; Cheng SY; Sunnybrook Health Sciences Centre, Toronto, Canada.; Bischoff HG; Thoraxklinik, Heidelberg, Germany.; Peled N; Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.; Reck M; LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.; Hui R; Department of Medical Oncology, Westmead Hospital and University of Sydney, Sydney, Australia.; Garon EB; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, USA.; Boyer M; Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, Australia.; Kurata T; Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan.; Yang J; Merck & Co., Inc., Kenilworth, USA.; Pietanza MC; Merck & Co., Inc., Kenilworth, USA.; Souza F; Merck & Co., Inc., Kenilworth, USA.; Garassino MC; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; University of Chicago Medicine & Biological Sciences, Knapp Center for Biomedical Discovery, Chicago, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Ponce Aix S; Hospital doce de Octubre, Medical Oncology Department Thoracic Cancer and Early Drug Development Unit, Madrid, Spain. Electronic address: sponceaix@gmail.com.; Novello S; Department of Oncology, University of Turin, AOU San Luigi, Orbassano, Italy.; Garon EB; David Geffen School of Medicine at University of California Los Angeles/TRIO-US Network, Santa Monica, CA, United States.; Nakagawa K; Kindai University Faculty of Medicine, Osaka, Japan.; Nadal E; Catalan Institute of Oncology L'Hospitalet, Barcelona, Spain.; Moro-Sibilot D; Centre Hospitalier Universitaire Grenoble Alpes, La Tronche, France.; Alonso Garcia M; Hospital Virgen del Rocío, Sevilla, Spain.; Fabre E; GHU Paris Ouest, Hôpital Européen Georges-Pompidou Service Oncologie Thoracique, Paris, France.; Frimodt-Moller B; Eli Lilly and Company, Copenhagen, Denmark.; Zimmermann AH; Eli Lilly and Company, Indianapolis, Indiana, United States.; Visseren-Grul CM; Eli Lilly and Company, Utrecht, Netherlands.; Reck M; Lungen Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.
Publisher: Elsevier Country of Publication: England NLM ID: 101694651 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-2942 (Electronic) Linking ISSN: 24682942 NLM ISO Abbreviation: Cancer Treat Res Commun Subsets: MEDLINE
Academic Journal
Hastings K; Yale Cancer Center, New Haven.; Yu HA; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York; Weill Cornell Medical College, New York.; Wei W; Yale School of Public Health, New Haven.; Sanchez-Vega F; Human Oncology and Pathogenesis Program; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering, New York.; DeVeaux M; Yale School of Public Health, New Haven.; Choi J; Department of Genetics, Yale School of Medicine, New Haven.; Rizvi H; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York.; Lisberg A; David Geffen School of Medicine, University of California Los Angeles, Los Angeles.; Truini A; Yale Cancer Center, New Haven.; Lydon CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston.; Liu Z; Department of Pathology, Yale School of Medicine, New Haven.; Henick BS; Herbert Irving Comprehensive Cancer Center, Columbia University, New York; Department of Medicine, Columbia University Medical Center, New York.; Wurtz A; Yale Cancer Center, New Haven.; Cai G; Department of Pathology, Yale School of Medicine, New Haven.; Plodkowski AJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York.; Long NM; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York.; Halpenny DF; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York.; Killam J; Department of Diagnostic Radiology, Yale School of Medicine, New Haven.; Oliva I; Department of Diagnostic Radiology, Yale School of Medicine, New Haven.; Schultz N; Human Oncology and Pathogenesis Program; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering, New York; Department of Epidemiology and Biostatistics.; Riely GJ; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York; Weill Cornell Medical College, New York.; Arcila ME; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York.; Ladanyi M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York.; Zelterman D; Yale School of Public Health, New Haven.; Herbst RS; Yale Cancer Center, New Haven; Department of Medicine (Section of Medical Oncology), Yale School of Medicine, New Haven, USA.; Goldberg SB; Yale Cancer Center, New Haven; Department of Medicine (Section of Medical Oncology), Yale School of Medicine, New Haven, USA.; Awad MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston.; Garon EB; David Geffen School of Medicine, University of California Los Angeles, Los Angeles.; Gettinger S; Yale Cancer Center, New Haven; Department of Medicine (Section of Medical Oncology), Yale School of Medicine, New Haven, USA.; Hellmann MD; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York; Weill Cornell Medical College, New York. Electronic address: hellmanm@mskcc.org.; Politi K; Yale Cancer Center, New Haven; Department of Pathology, Yale School of Medicine, New Haven; Department of Medicine (Section of Medical Oncology), Yale School of Medicine, New Haven, USA. Electronic address: katerina.politi@yale.edu.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Herbst RS; Department of Medical Oncology, Yale University School of Medicine, Yale Comprehensive Cancer Center, New Haven, USA. Electronic address: roy.herbst@yale.edu.; Baas P; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Perez-Gracia JL; Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain.; Felip E; Lung Cancer Unit, Department of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Kim DW; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Han JY; Division of Translational & Clinical Research, National Cancer Center, Goyang, Republic of Korea.; Molina JR; Department of Oncology, Mayo Clinic, Rochester, USA.; Kim JH; Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Gyeonggi-Do, Republic of Korea.; Dubos Arvis C; Department of Medicine, Centre François Baclesse, Caen, France.; Ahn MJ; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Majem M; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Fidler MJ; Division of Hematology Oncology, Rush University Medical Center, Chicago, USA.; Surmont V; Department of Respiratory Medicine/Thoracic Oncology, Universitar Ziekenhuis Ghent, Ghent, Belgium.; de Castro G Jr; Department of Medical Oncology, Instituto do Câncer do Estado de São Paulo, Sao Paulo, Brazil.; Garrido M; Department of Hemato-Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile.; Shentu Y; Department of Clinical Research, Merck & Co. Inc., Kenilworth, USA.; Emancipator K; Department of Clinical Research, Merck & Co. Inc., Kenilworth, USA.; Samkari A; Department of Clinical Research, Merck & Co. Inc., Kenilworth, USA.; Jensen EH; Department of Clinical Research, Merck & Co. Inc., Kenilworth, USA.; Lubiniecki GM; Department of Clinical Research, Merck & Co. Inc., Kenilworth, USA.; Garon EB; Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Hui R; Medical Oncology, Westmead Hospital and the University of Sydney, Sydney, Australia.; Garon EB; Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, USA.; Goldman JW; Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, USA.; Leighl NB; Department of Medicine, Princess Margaret Cancer Centre, Toronto, Canada.; Hellmann MD; Hematology/Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA.; Patnaik A; Oncology and Hematology Clinical Research, South Texas Accelerated Research Therapeutics, San Antonio, TX, USA.; Gandhi L; Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Eder JP; Medical Oncology, Yale University, New Haven, CT, USA.; Ahn MJ; Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Horn L; Thoracic Oncology, Vanderbilt Ingram Cancer Center, Nashville, TN, USA.; Felip E; Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Carcereny E; Medical Oncology, Catalan Institute of Oncology Badalona, Badalona, Spain.; Rangwala R; Medical Oncology, Merck & Co., Inc., Kenilworth, NJ, USA.; Lubiniecki GM; Medical Oncology, Merck & Co., Inc., Kenilworth, NJ, USA.; Zhang J; Medical Oncology, Merck & Co., Inc., Kenilworth, NJ, USA.; Emancipator K; Medical Oncology, Merck & Co., Inc., Kenilworth, NJ, USA.; Roach C; Companion Diagnostics, Dako, an Agilent Technologies Company, Carpinteria, CA, USA.; Rizvi NA; Thoracic Oncology, Columbia University, New York, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Lacouture ME; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA lacoutum@mskcc.org.; Keefe DM; Department of Medicine, Royal Adelaide Hospital, Adelaide, Australia.; Sonis S; Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston.; Jatoi A; Department of Oncology, Mayo Clinic, Rochester.; Gernhardt D; Pfizer Oncology, Groton.; Wang T; Pfizer Oncology, Groton.; Doherty JP; Pfizer Oncology, New York.; Giri N; Pfizer Oncology, La Jolla.; Nadanaciva S; Pfizer Oncology, Groton.; O'Connell J; Pfizer Oncology, New York.; Sbar E; Pfizer Oncology, Collegeville.; Piperdi B; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx.; Garon EB; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Chatterjee M; Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., Kenilworth, USA.; Turner DC; Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., Kenilworth, USA.; Felip E; Thoracic Tumors Group, Vall d'Hebron University Hospital, Barcelona, Spain.; Lena H; Pneumonology Service, Centre Hospitalier Universitaire Rennes, Rennes, France.; Cappuzzo F; Department of Medical Oncology, Istituto Toscano Tumori, Ospedale Civile, Livorno, Italy.; Horn L; Department of Medicine, Vanderbilt Ingram Cancer Center, Nashville, USA.; Garon EB; Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, USA.; Hui R; Department of Medical Oncology, Westmead Hospital and the University of Sydney, Sydney, Australia.; Arkenau HT; Department of Medical Oncology, Sarah Cannon Research Institute UK and University College London, London, UK.; Gubens MA; Department of Medicine, University of California, San Francisco, San Francisco.; Hellmann MD; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York.; Dong D; Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., Kenilworth, USA.; Li C; Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., Kenilworth, USA.; Mayawala K; Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., Kenilworth, USA.; Freshwater T; Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., Kenilworth, USA.; Ahamadi M; Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., Kenilworth, USA.; Stone J; Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., Kenilworth, USA.; Lubiniecki GM; Oncology Clinical Research, Merck & Co., Inc., Kenilworth.; Zhang J; Biostatistics and Research Design Sciences, Merck & Co., Inc., Kenilworth, USA.; Im E; Oncology Clinical Research, Merck & Co., Inc., Kenilworth.; De Alwis DP; Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., Kenilworth, USA.; Kondic AG; Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., Kenilworth, USA.; Fløtten Ø; Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway oystein.flotten@helse-bergen.no.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Giaccone G; National Cancer Institute, Bethesda, MD, USA. Electronic address: gg496@georgetown.edu.; Bazhenova LA; Moores Cancer Center, UC San Diego, La Jolla, CA, USA.; Nemunaitis J; Mary Crowley Cancer Research Centers, Dallas, TX, USA.; Tan M; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.; Juhász E; Korányi National Institute for TB and Pulmonology, Budapest, Hungary.; Ramlau R; Wielkopolskie Centrum Pulmonologii i Torakochirurgii, Poznań University of Medical Sciences, Poznan, Poland.; van den Heuvel MM; Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Thoracic Oncology, Amsterdam, Netherlands.; Lal R; Guy's Hospital, King's Health Partners, London, England, United Kingdom.; Kloecker GH; James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.; Eaton KD; Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA.; Chu Q; Cross Cancer Institute, Edmonton, Alberta, Canada.; Dunlop DJ; Royal Infirmary, Glasgow, Scotland, United Kingdom.; Jain M; Noble Hospital, Pune, India.; Garon EB; University of California, Los Angeles, Los Angeles, CA, USA.; Davis CS; CSD Biostatistics, Tucson, AZ, USA.; Carrier E; NovaRx Corporation, San Diego, CA, USA.; Moses SC; NovaRx Corporation, San Diego, CA, USA.; Shawler DL; NovaRx Corporation, San Diego, CA, USA.; Fakhrai H; NovaRx Corporation, San Diego, CA, USA.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Garon, E B
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어